Condition: Cancer · Sponsor: Sutter Health
The goal of this clinical trial is to assess whether Shengbai Oral Formula is a viable option for treatment of fatigue, pain, and neutropenia in patients undergoing their third cycle of chemotherapy.
This description comes directly from the study's public registry record.
Janet Han, BSN, RN · 510-204-4405 · janet.han@sutterhealth.org
Leila Murray, BSN, RN · 510-204-1608 · lilly.murray@sutterhealth.org
Always discuss trial participation with your own doctor first.
| Sutter Health | Oakland, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06706752